Search for: "Eli Lilly "
Results 1761 - 1780
of 2,131
Sorted by Relevance
|
Sort by Date
11 Jul 2011, 7:51 am
Eli Lilly Canada Inc. [read post]
8 Mar 2012, 3:34 am
Eli Lilly & Co. [read post]
24 Aug 2006, 7:34 am
See Eli Lilly & Co. v. [read post]
16 Aug 2011, 11:35 pm
PTO does not appear to invalidate very many gene patent method claims (Holman’s Biotech IP Blog) US: Machine-or-transformation test after Myriad: Implications to the prosecution of process claims (Patent Law Practice Center) US: Unsuccessful Qui Tam plaintiff asserting false marking claim not immune from costs award: Promote Innovation v Roche Diagnostics (Docket Report) US: FDA releases two medical device draft guidances (FDA Law Blog) US: BIO: Unleashing the promise of biotechnology (pt.4)… [read post]
4 Nov 2009, 9:44 am
e2 Moderator – David Berlind, Chief Content Officer, TechWeb Jamie Pappas, Manager, Social Media Strategy, EMC Bryce Williams, Social Media Consultant, Eli Lilly Megan Murray, Community Manager/Project Coordinator, Booz Allen Hamilton Claire Flanagan, Senior Manager, KM and Enterprise Social Collaboration, CSC Bruce Galinsky, Director IT, Metlife Greg Lowe, Social Media Architect/Program Manager, Alcatel-Lucent David started off by point out that this session was set up… [read post]
8 Apr 2014, 10:28 am
” And a jury in Lafayette, Louisiana just ordered Takeda Pharmaceutical and Eli Lilly & Co. [read post]
17 Sep 2011, 5:43 am
., Takeda Pharmaceuticals International Inc and Eli Lilly and Company), was negligent for not providing any warnings regarding the increased bladder cancer risk associated with Actos use. [read post]
28 Sep 2010, 3:14 pm
Eli Lilly & Co. [read post]
17 Sep 2015, 10:01 pm
As for Ronholm, he met Jan. 22 (and again on March 26) about Codex issues with representatives of Elanco, the animal feed production division of Ely Lilly and Company. [read post]
24 Apr 2017, 1:00 am
Eli Lilly & Co v Actavis UK Ltd & Ors, heard 4-6 Apr 2017. [read post]
3 Nov 2024, 5:29 pm
In one, Eli Lilly has challenged FDA’s decision to classify its anti-obesity product Retatrutide as drug instead of a biological. [read post]
14 Oct 2024, 5:54 am
In a nutshell, the FTC claimed that the PBMs’ rebate practices caused a 1,200% rise in the price of Humalog, a brand new Eli Lilly insulin medication, between 1999 and 2017. [read post]
28 Dec 2007, 1:00 am
International Trade Commission and Flexsys America: CAFC instructs the ITC on claim construction: (IPBiz), (Patent Prospector), (more from IPBiz)Anonymised net drug sales might yet infringe - Eli Lilly & Company and Lilly Icos LLC v 8PM Chemists Ltd: (IPKat),Open source for cost effective drug discovery: (Spicy IP),Challenges to ethical and generic drug producers: (Profitability through simplicity),US: multiple courts -… [read post]
25 Oct 2013, 1:50 am
In December, 2012, the SEC released its FCPA enforcement action against Eli Lilly and Company (Lilly). [read post]
21 Oct 2009, 5:13 am
In re KGK Synergize (non precedential) (Patently-O) US: Myriad sticks to its business model despite legal action brought by PUBPAT and others: Association for Molecular Pathology v USPTO (Patent Docs) US: Amazing race: Win $250,000 for commercialising biomedical research (Patent Baristas) US: BIO survey on technology transfer shows complexity of university-industry relationships (PatentBIOtech) Products Adderall (Dextroamphetamine, Amphetamine) - US: Shire announces settlement with Sandoz over… [read post]
27 May 2009, 4:09 am
"This is not the 1990s, when the industry was playing defense," says John Lechleiter, Eli Lilly & Co.'s chief executive. [read post]
15 Jun 2007, 6:37 am
It seems that Eli Lilly is complaining about attorney advertising unfairly influencing patients. [read post]
21 Oct 2009, 6:13 am
In re KGK Synergize (non precedential) (Patently-O) US: Myriad sticks to its business model despite legal action brought by PUBPAT and others: Association for Molecular Pathology v USPTO (Patent Docs) US: Amazing race: Win $250,000 for commercialising biomedical research (Patent Baristas) US: BIO survey on technology transfer shows complexity of university-industry relationships (PatentBIOtech) Products Adderall (Dextroamphetamine, Amphetamine) – US: Shire announces settlement… [read post]
23 Jun 2006, 4:50 am
Eli Lilly & Co., 256 U.S. 526 (1924). [read post]
21 Oct 2009, 5:13 am
In re KGK Synergize (non precedential) (Patently-O) US: Myriad sticks to its business model despite legal action brought by PUBPAT and others: Association for Molecular Pathology v USPTO (Patent Docs) US: Amazing race: Win $250,000 for commercialising biomedical research (Patent Baristas) US: BIO survey on technology transfer shows complexity of university-industry relationships (PatentBIOtech) Products Adderall (Dextroamphetamine, Amphetamine) - US: Shire announces settlement with Sandoz over… [read post]
